Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial.

Shimada K, Yamaguchi M, Kuwatsuka Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto A, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Meguro A, Kin Y, Minami Y, Hashimoto D, Nishiyama T, Shimada S, Masaki Y, Okamoto M, Atsuta Y, Kiyoi H, Suzuki R, Nakamura S, Kinoshita T

Open source

DOI: 10.1016/j.eclinm.2025.103078
Published: 2025 Feb
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2025.103078,
  title = {Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial.},
  author = {Shimada K and Yamaguchi M and Kuwatsuka Y and Matsue K and Sato K and Kusumoto S and Nagai H and Takizawa J and Fukuhara N and Nagafuji K and Miyazaki K and Ohtsuka E and Okamoto A and Sugita Y and Uchida T and Kayukawa S and Wake A and Ennishi D and Kondo Y and Meguro A and Kin Y and Minami Y and Hashimoto D and Nishiyama T and Shimada S and Masaki Y and Okamoto M and Atsuta Y and Kiyoi H and Suzuki R and Nakamura S and Kinoshita T},
  year = {2025},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2025.103078},
  url = {https://doi.org/10.1016/j.eclinm.2025.103078}
}

RIS

TY  - JOUR
TI  - Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial.
AU  - Shimada K
AU  - Yamaguchi M
AU  - Kuwatsuka Y
AU  - Matsue K
AU  - Sato K
AU  - Kusumoto S
AU  - Nagai H
AU  - Takizawa J
AU  - Fukuhara N
AU  - Nagafuji K
AU  - Miyazaki K
AU  - Ohtsuka E
AU  - Okamoto A
AU  - Sugita Y
AU  - Uchida T
AU  - Kayukawa S
AU  - Wake A
AU  - Ennishi D
AU  - Kondo Y
AU  - Meguro A
AU  - Kin Y
AU  - Minami Y
AU  - Hashimoto D
AU  - Nishiyama T
AU  - Shimada S
AU  - Masaki Y
AU  - Okamoto M
AU  - Atsuta Y
AU  - Kiyoi H
AU  - Suzuki R
AU  - Nakamura S
AU  - Kinoshita T
PY  - 2025
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2025.103078
UR  - https://doi.org/10.1016/j.eclinm.2025.103078
ER  -

APA

K, S., M, Y., Y, K., K, M., K, S., S, K., H, N., J, T., N, F., K, N., K, M., E, O., A, O., Y, S., T, U., S, K., A, W., D, E., Y, K., A, M., Y, K., Y, M., D, H., T, N., S, S., Y, M., M, O., Y, A., H, K., R, S., S, N., & T, K. (2025). Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2025.103078

Source records

pubmed · retrieved 2026-09-25T19:31:43.978Z